SEC Form 4 · accession 0000899243-19-003036
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nikhil Mehta
Officer — See Remarks
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.62 | Feb 6, 2019 | A | 450,000 | A | — | Feb 6, 2029 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal monthly installments from February 6, 2019 through February 6, 2023, subject to the Reporting Person's continued service to the Company.
Remarks
Senior Vice President, Regulatory Affairs and Quality Assurance